Literature DB >> 29535016

Risk factor, early diagnosis and overall survival on outcome of association between pancreatic cancer and diabetes mellitus: Changes and advances, a review.

Ramesh Khadka1, Weijun Tian2, Xin Hao3, Rakshya Koirala4.   

Abstract

To review literature addressing determination of the risk factor, early diagnosis and overall survival on outcome among patient of pancreatic cancer associated with diabetes mellitus from the perspective of pancreatic surgery. To identify recent guidelines, clinical pathogenesis, pathological classification, screening methodology and advances in surgical management. It identifies those clinical and surgical variables to predict excellent prognosis in respect of life style changes, ongoing advancement in therapeutic and surgical treatment and postoperative follow up. Approximately 85% pancreatic cancer have impaired glucose tolerance and may be associated with diabetes mellitus. Diabetes improves following pancreatic resection. This suggest diabetes is caused by pancreatic cancer. New onset glucose intolerance or DM is an earliest manifestation of pancreatic cancer. Recognition of new onset diabetes as an early manifestation of pancreatic cancer leads to diagnosis of asymptomatic, early stage pancreatic cancer. Thus, helps to aid in better diagnosis and therefore prolonging survival rate. Increasing duration of diabetes mellitus is significantly associated with decreasing risk of pancreatic cancer. Elderly patient with new onset diabetes have high risk of having pancreatic cancer compared to general population. New onset hyperglycemia and diabetes serves as an important screening tool to diagnose asymptomatic pancreatic cancer patient and improves pancreatic cancer related survival. DM in association with pancreatic cancer have reduced overall survival rate and increased mortality. Despite of having dismal prognosis of pancreatic cancer, many studies have concluded the survival rate of 5 years. There exists a bidirectional association between pancreatic cancer and DM is found to be a cause of pancreatic cancer as well as complication. The study on pancreatic cancer and diabetes has offered an interesting field of research based study and surgical practices.
Copyright © 2018 IJS Publishing Group Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Diabetes mellitus; Glucose intolerance; Mortality; Pancreatectomy; Pancreatic cancer

Mesh:

Year:  2018        PMID: 29535016     DOI: 10.1016/j.ijsu.2018.02.058

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  14 in total

1.  Clinical outcomes of pancreaticoduodenectomy for pancreatic ductal adenocarcinoma depending on preservation or resection of pylorus.

Authors:  Yeon Jin Kim; Sang Hyun Shin; In Woong Han; Youngju Ryu; Naru Kim; Dong Wook Choi; Jin Seok Heo
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2020-08-31

2.  Pancreatic cystic lesions in diabetes mellitus patients.

Authors:  Martyna Rozek; Michal Lipinski; Ewa Jozefik; Zuzanna Znajdek; Marta Kiziak; Marta Sznurkowska; Jacek Tatur; Malgorzata Degowska; Grazyna Rydzewska
Journal:  Prz Gastroenterol       Date:  2020-06-04

3.  Identification of the Shared Gene Signatures and Biological Mechanism in Type 2 Diabetes and Pancreatic Cancer.

Authors:  Yifang Hu; Ni Zeng; Yaoqi Ge; Dan Wang; Xiaoxuan Qin; Wensong Zhang; Feng Jiang; Yun Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-31       Impact factor: 5.555

Review 4.  The relationship between pancreatic cancer and type 2 diabetes: cause and consequence.

Authors:  Yan Li; Xiaohui Bian; Shuyi Wei; Meizhi He; Yuelian Yang
Journal:  Cancer Manag Res       Date:  2019-09-09       Impact factor: 3.989

5.  LncRNA C9orf139 can regulate the growth of pancreatic cancer by mediating the miR-663a/Sox12 axis.

Authors:  Jin-Nian Ge; Di Yan; Chun-Lin Ge; Min-Jie Wei
Journal:  World J Gastrointest Oncol       Date:  2020-11-15

6.  Enlarged adipocytes from subcutaneous vs. visceral adipose tissue differentially contribute to metabolic dysfunction and atherogenic risk of patients with obesity.

Authors:  Gustavo De La Peña-Sosa; Karen De La Vega-Moreno; Diana Zaineff Banderas-Lares; Moisés Salamanca-García; José Enrique Martínez-Hernández; Eduardo Vera-Gómez; Alejandro Hernández-Patricio; Carlos Ramiro Zamora-Alemán; Gabriela Alexandra Domínguez-Pérez; Atzín Suá Ruíz-Hernández; Moisés Ortíz-Fernández; Jesús Montoya-Ramírez; Omar Felipe Gaytán-Fuentes; Angélica Toríz-Ortíz; Mario Osorio-Valero; Juan Antonio Suárez-Cuenca; Juan Ariel Gutiérrez-Buendía; Alberto Melchor-López; Julita Orozco-Vázquez; Sofía Lizeth Alcaráz-Estrada; Martha Eunice Rodríguez-Arellano; Brenda Maldonado-Arriaga; Rebeca Pérez-Cabeza de Vaca; Mónica Escamilla-Tilch; Juan Antonio Pineda-Juárez; Mario Antonio Téllez-González; Silvia García; Paul Mondragón-Terán
Journal:  Sci Rep       Date:  2021-01-19       Impact factor: 4.379

7.  Pyroptosis regulators exert crucial functions in prognosis, progression and immune microenvironment of pancreatic adenocarcinoma: a bioinformatic and in vitro research.

Authors:  Zhenghai Bai; Fangshi Xu; Xiaodan Feng; Yuan Wu; Junhua Lv; Yu Shi; Honghong Pei
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

Review 8.  Non-coding RNAs underlying the pathophysiological links between type 2 diabetes and pancreatic cancer: A systematic review.

Authors:  Fariba Dehghanian; Zahra Azhir; Sheyda Khalilian; Björn Grüning
Journal:  J Diabetes Investig       Date:  2021-12-14       Impact factor: 4.232

9.  The association of Helicobacter pylori with pancreatic cancer.

Authors:  Shria Kumar; David C Metz; David E Kaplan; David S Goldberg
Journal:  GastroHep       Date:  2020-05-05

Review 10.  Modulatory Mechanisms of the NLRP3 Inflammasomes in Diabetes.

Authors:  Sujuan Ding; Sheng Xu; Yong Ma; Gang Liu; Hongmei Jang; Jun Fang
Journal:  Biomolecules       Date:  2019-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.